The Enterprise Value as of November 2024 (TTM) for PMV Pharmaceuticals, Inc. (PMVP) is 47.77M

According to PMV Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 47.77M. This represents a change of -30.93% compared to the average of 69.16M of the last 4 quarters.

PMV Pharmaceuticals, Inc. (PMVP) Historical Enterprise Value (quarterly & annually)

How has PMVP Enterprise Value performed in the past?

The mean historical Enterprise Value of PMV Pharmaceuticals, Inc. over the last ten years is 1.11B. The current 47.77M Enterprise Value has changed 330.48% with respect to the historical average. Over the past ten years (40 quarters), PMVP's Enterprise Value was at its highest in in the June 2020 quarter at 1.46B. The Enterprise Value was at its lowest in in the September 2020 quarter at -159352776.50.

PMV Pharmaceuticals, Inc. (PMVP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PMV Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PMV Pharmaceuticals, Inc. (PMVP) Average Enterprise Value

How has PMVP Enterprise Value performed in the past?

The current Enterprise Value of PMV Pharmaceuticals, Inc. (PMVP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PMV Pharmaceuticals, Inc. (PMVP) Enterprise Value vs. Peers

How is PMVP’s Enterprise Value compared to its peers?

PMV Pharmaceuticals, Inc.’s Enterprise Value is less than Eliem Therapeutics, Inc. (119.64M), greater than MediciNova, Inc. (-41974173594.00), less than Pharvaris N.V. (850.00M), less than PepGen Inc. (120.50M), greater than Anebulo Pharmaceuticals, Inc. (36.46M), less than Acrivon Therapeutics, Inc. Common Stock (163.47M), less than Molecular Partners AG (130.63M), less than Mineralys Therapeutics, Inc. (523.81M), less than Edgewise Therapeutics, Inc. (3.01B), greater than Rallybio Corporation (17.23M), less than Opthea Limited (514.42M), less than Monte Rosa Therapeutics, Inc. (439.72M), less than Entrada Therapeutics, Inc. (686.76M), less than Vigil Neuroscience, Inc. (98.69M),

Build a custom stock screener for PMV Pharmaceuticals, Inc. (PMVP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PMV Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PMV Pharmaceuticals, Inc. (PMVP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PMV Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.